Rimegepant: Effective Relief for Menstrual Migraines in Women
- Apr 4
- 1 min read
Research Summary
A recent study published in BMC Neurology explores the efficacy and safety of rimegepant for treating pure menstrual migraines in Chinese women. The research, conducted as a retrospective observational study, highlights that rimegepant significantly reduced migraine frequency by 43% over the study period. Additionally, 56% of participants reported substantial relief from migraine symptoms. The study also confirms the safety profile of rimegepant, with only 7% experiencing mild side effects, such as nausea and dizziness. These findings suggest that rimegepant could be a promising treatment option for menstrual migraines, offering both effectiveness and safety for women affected by this condition.
Study Details
👥 Research Team: Ye W et al.
📚 Published In: BMC Neurol
📅 Publication Date: 2026 Apr 2
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.